SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$18.73
−1.16%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $0.27
- Revenue estimate
- $319.8M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.26
- EPS estimate
- $0.24
- Revenue actual
- $321.4M
- Revenue estimate
- $309.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +10.3%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $23
- PT range
- $18 – $25
- Analysts
- 4
3 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.24 | $0.26 | Beat 8.83% | $321.4M |
| May 5, 2026 | $0.17 | $0.18 | Beat 5.88% | $280.0M |
| Feb 24, 2026 | $0.24 | $0.26 | Beat 8.33% | $303.4M |
| Nov 4, 2025 | $0.22 | $0.26 | Beat 18.18% | $311.3M |
| Aug 8, 2025 | $0.17 | $0.20 | Beat 17.65% | $294.3M |
| May 1, 2025 | $0.12 | $0.14 | Beat 16.67% | $254.5M |
| Feb 27, 2025 | $0.21 | $0.21 | In line | $290.2M |
| May 2, 2024 | $0.14 | $0.13 | Miss -6.47% | $248.2M |
| Feb 27, 2024 | $0.26 | $0.26 | Beat 0.39% | $310.2M |
| Nov 1, 2023 | $0.21 | $0.21 | In line | $263.2M |
| Aug 3, 2023 | $0.18 | $0.21 | Beat 15.38% | $255.3M |
| May 3, 2023 | $0.14 | $0.13 | Miss -8.45% | $220.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026